Literature DB >> 16328761

[The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives].

H-J Lakomek1, W Fiori, K Buscham, J L Hülsemann, N Köneke, W Liman, E Märker-Hermann, N Roeder.   

Abstract

As from 2005 the specialized complex rheumatologic treatment can be assigned to the code category 8-983 (Multimodale rheumatologische Komplexbehandlung) of the OPS procedure classification system. Only by means of this specific procedure code, has an appropriate description and consideration in the G-DRG system of the common clinical practice in specialized rheumatologic hospitals/clinics become possible. The complex and multimodal treatment reflects the rheumatologic therapeutic standard for the treatment of inflammatory rheumatic diseases and non-inflammatory pain syndromes. The article focuses on the minimal criteria that have to be met for coding the OPS 8-983. Helpful practical instructions are given concerning how to implement the complex procedure into practice. Even though the newly introduced procedure code OPS 8-983 will not yet develop influence on the grouping process in 2005, other changes in the GDRG system lead to an improved economic valuation of rheumatological services in comparison to 2004.

Entities:  

Mesh:

Year:  2005        PMID: 16328761     DOI: 10.1007/s00393-005-0783-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  5 in total

1.  [Rheumatology coding guideline. A guideline for clinical practice].

Authors:  H J Lakomek; J L Hülsemann; N Koeneke; H Lehmann; H J Bergerhausen; W Fiori; N Loskamp; N Roeder
Journal:  Z Rheumatol       Date:  2002-06       Impact factor: 1.372

2.  [Rheumatologic treatment in the G-DRG system].

Authors:  N Roeder; W Fiori; J L Hülsemann; N Könecke; H Lehmann; W Liman; H-J Lakomek
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

3.  [Changes for rheumatology in the G-DRG system 2005].

Authors:  W Fiori; N Roeder; H-J Lakomek; W Liman; N Köneke; J L Hülsemann; H Lehmann; A Wenke
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

4.  [Structural quality of acute internal medicine rheumatology clinics--Project Group of the Association of Rheumatologic Acute Clinics].

Authors:  H J Lakomek; G Neeck; B Lang; J Jung
Journal:  Z Rheumatol       Date:  2002-08       Impact factor: 1.372

5.  [Clinical pathways: effective and efficient inpatient treatment].

Authors:  N Roeder; P Hensen; D Hindle; N Loskamp; H-J Lakomek
Journal:  Chirurg       Date:  2003-12       Impact factor: 0.955

  5 in total
  14 in total

1.  [What changes for rheumatologists in the G-DRG system 2006?].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; J L Hülsemann; N Köneke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

2.  [Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006].

Authors:  H J Lakomek; W Fiori; K Buscham; J Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

Review 3.  [Clinical pathways in rheumatological inpatient treatment - a structured process management].

Authors:  H-J Lakomek; J L Hülsemann; T Küttner; K Buscham; N Roeder
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

4.  [Changes for the field of rheumatology in the G-DRG-System 2007].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; A Wenke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

5.  [The G-DRG system 2008. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; J L Hülsemann; N Roeder
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

6.  [Amendment of the structural quality for inpatient rheumatology. A forward-looking concept].

Authors:  H-J Lakomek; J Braun; E Gromnica-Ihle; C Fiehn; S Claus; C Specker; J Jung; A Krause; H-M Lorenz; J Robbers
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

7.  [Multimodal rheumatologic complex treatment of rheumatoid arthritis-a monocentric retrospective analysis].

Authors:  P Klemm; O Hudowenz; T Asendorf; U Müller-Ladner; U Lange; I H Tarner
Journal:  Z Rheumatol       Date:  2019-03       Impact factor: 1.372

Review 8.  [The elder patient with a rheumatic disease and comorbidities. Aspects of rheumatology in an ageing population].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

9.  [Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].

Authors:  A Zink; J Braun; E Gromnica-Ihle; D Krause; H J Lakomek; W Mau; U Müller-Ladner; J Rautenstrauch; C Specker; M Schneider
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

10.  Evaluation of a special concept of physical therapy in spondyloarthritis: German multimodal rheumatologic complex treatment for spondyloarthritis.

Authors:  Philipp Klemm; Ole Hudowenz; Thomas Asendorf; Gabriel Dischereit; Ulf Müller-Ladner; Uwe Lange; Ingo H Tarner
Journal:  Clin Rheumatol       Date:  2020-01-08       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.